JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3676
Monro
MNRO
$438M
| $807K | ﹤0.01% |
14,170
+6,671
| +89% | +$347K |
2015 Q4
8 quarters
|
|
|
SP
3677
DELISTED
SP Plus Corporation
SP
| $807K | ﹤0.01% |
+21,768
| New | +$846K |
2017 Q4
0 quarters
|
|
|
XOXO
3678
DELISTED
Xo Group Inc
XOXO
| $805K | ﹤0.01% |
43,595
+14,946
| +52% | +$290K |
2016 Q2
6 quarters
|
|
|
GOL
3679
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $803K | ﹤0.01% |
91,699
-3,734
| -4% | -$32.8K |
2017 Q2
2 quarters
|
|
3680
State Street SPDR S&P Pharmaceuticals ETF
XPH
$526M
| $800K | ﹤0.01% |
18,389
-83,330
| -82% | -$3.54M |
2015 Q4
8 quarters
|
|
|
ARAV
3681
DELISTED
Aravive, Inc. Common Stock
ARAV
| $800K | ﹤0.01% |
60,574
-90,684
| -60% | -$1.17M |
2014 Q2
14 quarters
|
|
3682
ASE Group
ASX
$116B
| $799K | ﹤0.01% |
123,394
+2,752
| +2% | +$17.4K |
2013 Q2
18 quarters
|
|
3683
First Trust Water ETF
FIW
$1.72B
| $799K | ﹤0.01% |
16,400
+4,650
| +40% | +$220K |
2017 Q3
1 quarter
|
|
|
KG
3684
Kestrel Group
KG
$38.9M
| $797K | ﹤0.01% |
6,036
-41
| -0.7% | -$6.14K |
2013 Q2
18 quarters
|
|
3685
CALL
MiMedx Group
MDXG
$677M
| $794K | ﹤0.01% |
+63,000
| New | +$768K |
2017 Q4
0 quarters
|
|
|
AE
3686
DELISTED
Adams Resources & Energy Inc
AE
| $793K | ﹤0.01% |
18,219
-231
| -1% | -$10.3K |
2014 Q2
14 quarters
|
|
|
VSTO
3687
DELISTED
Vista Outdoor Inc.
VSTO
| $793K | ﹤0.01% |
54,460
-56,664
| -51% | -$989K |
2015 Q1
11 quarters
|
|
3688
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.35B
| $786K | ﹤0.01% |
12,842
-237
| -2% | -$14.2K |
2013 Q2
18 quarters
|
|
3689
LeMaitre Vascular
LMAT
$1.83B
| $784K | ﹤0.01% |
24,625
-30,594
| -55% | -$1.05M |
2016 Q3
5 quarters
|
|
3690
Artesian Resources
ARTNA
$340M
| $783K | ﹤0.01% |
20,322
-3,016
| -13% | -$121K |
2013 Q2
18 quarters
|
|
|
RDFN
3691
PUT
DELISTED
Redfin
RDFN
| $783K | ﹤0.01% |
+25,000
| New | +$607K |
2017 Q4
0 quarters
|
|
3692
Weyco Group
WEYS
$480M
| $783K | ﹤0.01% |
+26,334
| New | +$740K |
2017 Q4
0 quarters
|
|
|
BKMU
3693
DELISTED
Bank Mutual Corp
BKMU
| $782K | ﹤0.01% |
73,516
-12,562
| -15% | -$131K |
2015 Q4
8 quarters
|
|
3694
Gladstone Capital
GLAD
$439M
| $777K | ﹤0.01% |
42,200
-1,359
| -3% | -$26.2K |
2015 Q4
8 quarters
|
|
3695
Select Water Solutions
WTTR
$2.58B
| $775K | ﹤0.01% |
42,460
+40,361
| +1,923% | +$647K |
2017 Q3
1 quarter
|
|
3696
Titan International
TWI
$439M
| $773K | ﹤0.01% |
60,058
+56,071
| +1,406% | +$623K |
2015 Q4
8 quarters
|
|
3697
Forrester Research
FORR
$221M
| $770K | ﹤0.01% |
17,415
+2,064
| +13% | +$92.6K |
2016 Q2
6 quarters
|
|
3698
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.74B
| $770K | ﹤0.01% |
7,669
+92
| +1% | +$9.28K |
2013 Q2
18 quarters
|
|
3699
iShares MSCI Singapore ETF
EWS
$1.39B
| $767K | ﹤0.01% |
29,571
+1,262
| +4% | +$32.4K |
2013 Q2
18 quarters
|
|
|
BEDU
3700
DELISTED
Bright Scholar Education Holdings
BEDU
| $762K | ﹤0.01% |
10,198
-4,661
| -31% | -$406K |
2017 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.